Financial & competing interests disclosure
Joseph Patti is corporate officer and shareholder at Inhibitex, Inc. Pfizer is developing a Staphylococcus aureus vaccine that contains a protein licensed from Inhibitex Inc., and it would receive royalties if the vaccine was commercialized. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.